(CUK) Carnival ADS - Ratings and Ratios
Cruise Vacations, Port Destinations, Hotels, Railcars
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 46.2% |
| Value at Risk 5%th | 69.0% |
| Relative Tail Risk | -9.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.10 |
| Alpha | -22.44 |
| CAGR/Max DD | 1.03 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.494 |
| Beta | 1.752 |
| Beta Downside | 1.789 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.10% |
| Mean DD | 13.98% |
| Median DD | 12.92% |
Description: CUK Carnival ADS December 03, 2025
Carnival Corporation & plc (NYSE:CUK) is the world’s largest cruise operator, delivering leisure travel across North America, Europe, Australia and other international markets. The firm runs four business segments-North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour & Other-and markets its voyages through a portfolio of brands that includes Carnival Cruise Line, Princess, Holland America, Costa, AIDA, Cunard, P&O (UK & Australia), and Seabourn. Distribution channels span travel agents, online platforms, and onboard future-cruise consultants, while ancillary assets such as hotels, railcars, and motorcoaches support the cruise experience.
Key operating metrics as of Q2 2024 show an average occupancy of roughly 85% and a yield per passenger-day of about $120, reflecting a rebound from pandemic lows but still below the 2019 peak of ~95% occupancy. The company’s cash-flow generation remains pressured by a $30 bn long-term debt load and exposure to volatile bunker fuel prices, which are closely tied to global oil markets and the broader consumer-discretionary cycle. Macro-drivers such as U.S. consumer confidence, discretionary income trends, and the pace of post-COVID travel demand are critical determinants of future revenue growth.
For a deeper, data-driven view of Carnival’s valuation and scenario analysis, the ValueRay platform provides a structured set of metrics worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (2.64b TTM) > 0 and > 6% of Revenue (6% = 1.57b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 3.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -28.85% (prev -35.29%; Δ 6.44pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 5.61b > Net Income 2.64b (YES >=105%, WARN >=100%) |
| Net Debt (26.10b) to EBITDA (6.79b) ratio: 3.84 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.34 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.40b) change vs 12m ago 0.21% (target <= -2.0% for YES) |
| Gross Margin 39.49% (prev 36.95%; Δ 2.55pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.63% (prev 49.15%; Δ 3.48pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.87 (EBITDA TTM 6.79b / Interest Expense TTM 1.42b) >= 6 (WARN >= 3) |
Altman Z'' -0.07
| (A) -0.15 = (Total Current Assets 3.87b - Total Current Liabilities 11.44b) / Total Assets 49.87b |
| (B) 0.09 = Retained Earnings (Balance) 4.39b / Total Assets 49.87b |
| (C) 0.08 = EBIT TTM 4.07b / Avg Total Assets 49.84b |
| (D) 0.08 = Book Value of Equity 3.05b / Total Liabilities 37.94b |
| Total Rating: -0.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.11
| 1. Piotroski 5.0pt |
| 2. FCF Yield 5.06% |
| 3. FCF Margin 11.11% |
| 4. Debt/Equity 2.34 |
| 5. Debt/Ebitda 3.84 |
| 6. ROIC - WACC (= 3.81)% |
| 7. RoE 26.18% |
| 8. Rev. Trend 83.67% |
| 9. EPS Trend 76.21% |
What is the price of CUK shares?
Over the past week, the price has changed by -0.13%, over one month by -1.37%, over three months by -17.28% and over the past year by +3.38%.
Is CUK a buy, sell or hold?
What are the forecasts/targets for the CUK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 34.5 | 44.7% |
| Analysts Target Price | 34.5 | 44.7% |
| ValueRay Target Price | 25.1 | 5.4% |
CUK Fundamental Data Overview December 05, 2025
P/E Trailing = 12.3454
P/E Forward = 11.1483
P/S = 1.2013
P/B = 2.6278
P/EG = 0.6125
Beta = 2.527
Revenue TTM = 26.23b USD
EBIT TTM = 4.07b USD
EBITDA TTM = 6.79b USD
Long Term Debt = 25.06b USD (from longTermDebt, last quarter)
Short Term Debt = 1.59b USD (from shortTermDebt, last quarter)
Debt = 27.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 26.10b USD (from netDebt column, last quarter)
Enterprise Value = 57.61b USD (31.51b + Debt 27.86b - CCE 1.76b)
Interest Coverage Ratio = 2.87 (Ebit TTM 4.07b / Interest Expense TTM 1.42b)
FCF Yield = 5.06% (FCF TTM 2.91b / Enterprise Value 57.61b)
FCF Margin = 11.11% (FCF TTM 2.91b / Revenue TTM 26.23b)
Net Margin = 10.07% (Net Income TTM 2.64b / Revenue TTM 26.23b)
Gross Margin = 39.49% ((Revenue TTM 26.23b - Cost of Revenue TTM 15.87b) / Revenue TTM)
Gross Margin QoQ = 46.22% (prev 38.59%)
Tobins Q-Ratio = 1.16 (Enterprise Value 57.61b / Total Assets 49.87b)
Interest Expense / Debt = 1.06% (Interest Expense 296.0m / Debt 27.86b)
Taxrate = 0.32% (6.00m / 1.86b)
NOPAT = 4.06b (EBIT 4.07b * (1 - 0.32%))
Current Ratio = 0.34 (Total Current Assets 3.87b / Total Current Liabilities 11.44b)
Debt / Equity = 2.34 (Debt 27.86b / totalStockholderEquity, last quarter 11.93b)
Debt / EBITDA = 3.84 (Net Debt 26.10b / EBITDA 6.79b)
Debt / FCF = 8.96 (Net Debt 26.10b / FCF TTM 2.91b)
Total Stockholder Equity = 10.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.30% (Net Income 2.64b / Total Assets 49.87b)
RoE = 26.18% (Net Income TTM 2.64b / Total Stockholder Equity 10.09b)
RoCE = 11.58% (EBIT 4.07b / Capital Employed (Equity 10.09b + L.T.Debt 25.06b))
RoIC = 10.92% (NOPAT 4.06b / Invested Capital 37.15b)
WACC = 7.12% (E(31.51b)/V(59.37b) * Re(12.47%) + D(27.86b)/V(59.37b) * Rd(1.06%) * (1-Tc(0.00)))
Discount Rate = 12.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.36%
[DCF Debug] Terminal Value 53.40% ; FCFE base≈2.24b ; Y1≈1.47b ; Y5≈672.2m
Fair Price DCF = 52.25 (DCF Value 7.61b / Shares Outstanding 145.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 76.21 | EPS CAGR: 166.0% | SUE: -3.07 | # QB: 0
Revenue Correlation: 83.67 | Revenue CAGR: 63.61% | SUE: 0.01 | # QB: 0
EPS next Year (2026-11-30): EPS=2.14 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+0.5% | Growth Revenue=+4.3%
Additional Sources for CUK Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle